EFFICACY OF CARBOPLATIN plus WEEKLY NAB-PACLITAXEL FOR ELDERLY ADVANCED/RECURRENT NON-SMALL CELL LUNG CANCER (E-NSCLC)

被引：0
|
作者：
Shibata, Kazuhiko [1 ,2 ]
Shibata, Yoshihiro [1 ]
Takase, Misae [2 ]
Takahashi, Miyuki [2 ,3 ]
机构：
[1] Koseiren Takaoka Hosp, Dept Med Oncol, Toyama, Japan
[2] Koseiren Takaoka Hosp, Comprehens Canc Ctr, Toyama, Japan
[3] Koseiren Takaoka Hosp, Dept Nursing, Toyama, Japan
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
10.1093/annonc/mdu436.35
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-17-4
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase 2 study of bevacizumab plus carboplatin/nab-paclitaxel followed by bevacizumab plus nab-paclitaxel for non-squamous non-small cell lung cancer with malignant pleural effusion
    Tamiya, Motohiro
    Tamiya, Akihiro
    Suzuki, Hidekazu
    Taniguchi, Yoshihiko
    Katayama, Kanako
    Minomo, Shojiro
    Nakao, Keiko
    Takeuchi, Naoko
    Matsuda, Yoshinobu
    Naito, Yujiro
    Shiroyama, Takayuki
    Okamoto, Norio
    Okishio, Kyoichi
    Kumagai, Toru
    Atagi, Shinji
    Imamura, Fumio
    Hirashima, Tomonori
    INVESTIGATIONAL NEW DRUGS, 2021, 39 (04) : 1106 - 1112
  • [42] nab-Paclitaxel (nab-P) plus carboplatin (C) as first-line treatment in patients with advanced non-small cell lung cancer (NSCLC): Clinical outcomes by treatment cycle
    Gridelli, C.
    Li, L.
    O'Brien, M.
    Ong, T. J.
    Pirker, R.
    Socinski, M. A.
    Thomas, M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S638 - S639
  • [43] Phase I/II study of carboplatin plus nab-paclitaxel and concurrent radiotherapy for patients with locally advanced non-small cell lung cancer
    Kawano, Yuko
    Sasaki, Tomonari
    Yamaguchi, Hiroyuki
    Hirano, Katsuya
    Horiike, Atsushi
    Satouchi, Miyako
    Hosokawa, Shinobu
    Morinaga, Ryotaro
    Komiya, Kazutoshi
    Inoue, Koji
    Fujita, Yuka
    Toyozawa, Ryo
    Kimura, Tomoki
    Takahashi, Kosuke
    Nishikawa, Kazuo
    Kishimoto, Junji
    Nakanishi, Yoichi
    Okamoto, Isamu
    LUNG CANCER, 2018, 125 : 136 - 141
  • [44] First-line nab-paclitaxel plus carboplatin for patients with advanced non-small cell lung cancer: Final results of the NEPTUN study
    Dechow, Tobias
    Riera-Knorrenschild, Jorge
    Hackanson, Bjorn
    Janssen, Jan
    Schulz, Holger
    Oppermann, Ursula
    Chiabudini, Marco
    von Weikersthal, Ludwig Fischer
    Budweiser, Stephan
    Nacke, Axel
    Taeuscher, Dagmar
    Welslau, Manfred
    Potthoff, Karin
    INTERNATIONAL JOURNAL OF CANCER, 2023, 153 (01) : 141 - 152
  • [45] Phase I study of nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancer
    Kaira, Kyoichi
    Tomizawa, Yoshio
    Imai, Hisao
    Sakurai, Reiko
    Matsuura, Masana
    Yoshii, Akihiro
    Ochiai, Mai
    Kotake, Mie
    Ebara, Takeshi
    Saitoh, Jun-ichi
    Sunaga, Noriaki
    Minato, Koichi
    Saito, Ryusei
    Hisada, Takeshi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (01) : 165 - 171
  • [46] Phase I study of nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancer
    Kyoichi Kaira
    Yoshio Tomizawa
    Hisao Imai
    Reiko Sakurai
    Masana Matsuura
    Akihiro Yoshii
    Mai Ochiai
    Mie Kotake
    Takeshi Ebara
    Jun-ichi Saitoh
    Noriaki Sunaga
    Koichi Minato
    Ryusei Saito
    Takeshi Hisada
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 165 - 171
  • [47] Efficacy and Adverse Reactions of Carboplatin, Nab-Paclitaxel Regimen Combined with Atezolizumab in the Treatment of Non-Small Cell Lung Cancer
    Li, Li
    Xu, Zhensheng
    Lin, Wei
    Lu, Wei
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 84 : 1 - 6
  • [48] Efficacy and safety of nab-paclitaxel plus platinum in non-small cell lung cancer: a meta-analysis
    Tan, Tianying
    Li, Shuangshuang
    Hu, Wenting
    Yue, Tinghui
    Zeng, Qi
    Zeng, Xingling
    Chen, Xiaochao
    Zhao, Xiangdong
    Xiao, Tianbao
    FRONTIERS IN MEDICINE, 2023, 10
  • [49] Bevacizumab Plus Carboplatin Plus Nab-paclitaxel for Non-squamous Non-small Cell Lung Cancer in a Real-world Setting
    Tamiya, Akihiro
    Tamiya, Motohiro
    Inagaki, Yuji
    Taniguchi, Yoshihiko
    Nakao, Keiko
    Matsuda, Yoshinobu
    Kawamura, Takahisa
    Kunimasa, Kei
    Inoue, Takako
    Nishino, Kazumi
    Okishio, Kyoichi
    ANTICANCER RESEARCH, 2023, 43 (03) : 1325 - 1330
  • [50] Paclitaxel Carboplatin in Elderly Patients with Advanced Non-Small Cell Lung Cancer
    Kanat, Ozkan
    Cubukcu, Erdem
    Cubukcu, Sinem
    Aksoy, Savas
    Canhoroz, Mustafa
    Karadag, Oya
    Alkis, Nihan
    Manavolglu, Osman
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2012, 3 (03) : 293 - 295
12345